Company news

Charles River Laboratories International, Inc. news in 2026

Charles River Laboratories International, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Charles River Laboratories Announces Third-Quarter 2026 Results

November 4, 2026

Charles River Leverages Virtual Control Groups in GLP Studies

October 27, 2026

Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment

October 22, 2026

Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development

October 13, 2026

Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call

October 9, 2026

Charles River and Autolomous Partner to Transform Laboratory Execution Systems

October 6, 2026

Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day

September 24, 2026

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

September 17, 2026

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

September 11, 2026

Charles River Modernizes Endosafe(R) Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

September 9, 2026

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

September 8, 2026

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing

August 20, 2026

Charles River Laboratories Announces Second-Quarter 2026 Results

August 5, 2026

Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call

July 15, 2026

Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

July 13, 2026

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

June 18, 2026

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

May 13, 2026

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

May 11, 2026

Charles River Laboratories Announces First-Quarter 2026 Results

May 7, 2026

Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

April 30, 2026

Charles River Highlights Effectiveness of VCGs in Toxicology

April 21, 2026

Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call

April 16, 2026

Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association

April 9, 2026

NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore

April 8, 2026

Charles River Laboratories to Present at TD Cowen and Barclays Conferences

March 2, 2026

Charles River Laboratories Provides Update on Planned Divestitures

February 25, 2026

Charles River Laboratories Announces Executive Appointments

February 18, 2026

Charles River Wealth to Expand Capabilities Supporting Private Assets within Unified Managed Accounts (UMA)

January 22, 2026

Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call

January 21, 2026

Charles River Enters Manufacturing Collaboration with Gazi University

January 21, 2026

Charles River Laboratories Provides Business Updates

January 12, 2026

Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

January 8, 2026

Calls in 2026

Decks in 2026